Biopharma pharmaceutical company (Kyiv) plans to invest $7 million in construction of new office and laboratory complex.
The company told Interfax-Ukraine that the complex will be built on the territory of its plant in Bila Tserkva (Kyiv region).
“Some of the facilities in the territory of the scientific and production complex [in Bila Tserkva] were sold to STADA Ukraine. We decided to build a new building. It will be a separate building from the building of the fractionator plant,” the company said.
In addition, the company said that Biopharma sent $500,000 to buy laboratory equipment for the diagnosis of COVID-19, test systems, artificial lung ventilators, and blood gas analyzers.
Biopharma is a Ukrainian biotechnology company, the only plant in Eastern Europe that has modern technology, has been manufacturing and developing drugs from donated plasma for almost 50 years.
